<DOC>
	<DOC>NCT00719121</DOC>
	<brief_summary>The purpose of this exploratory trial is to assess the anti-inflammatory effect(s) of topical R115866 in a model of UVB-induced inflammation and in a model of cutaneous irritation.</brief_summary>
	<brief_title>Study on Anti-inflammatory Effects of Topical R115866 Gel</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Adapalene</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>R 115866</mesh_term>
	<criteria>Body Mass Index should be between 18 and 28 kg/m2 Subjects are healthy as determined by medical history, physical examination and clinical laboratory tests carried out at screening Subjects with a phototype III or IV (according to Fitzpatrick classification) Subjects with history of or active alcohol or substance abuse problems. Known hypersensitivity to azoles, adapalene, retinoids or any other ingredient of the gels Subjects who have a laboratory value which, in the opinion of the investigator, is clinicallyrelevant out of the normal range Subjects with clinically relevant abnormal ECGintervals or morphology of the ECG, QTc interval &gt;450 ms Use of vitamin A (&gt;1000 Âµg/day) or the use of concomitant medication, except paracetamol; All other medication must have been stopped at least 14 days before the first administration of gel) Subjects who have received an investigational product which is not a biological within the month preceding the screening visit; If the investigational product is a biological, a 3month washout period is required. Use of ultraviolet light (including artificial UVA and UVB as well as excessive natural sun exposure) unless stopped at Visit 1 Subjects judged by the investigator to have a high probability of lack of compliance with the provisions of the protocol Subjects having any medical condition which, in the opinion of the investigator at the site, is a contraindication to enrollment</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2008</verification_date>
</DOC>